Abstract:Cells react to physical (e.g., heat) or chemical (e.g., anoxia, low pH) stressors, mounting a stress (heat-shock) response. Most genes are turned down or off, while a few are activated. The latter encode the stress or heat-shock proteins (Hsps), whose levels increase in stressed cells. Various Hsps are molecular chaperones. These, and other molecular chaperones that are not Hsps, help the other cellular proteins to achieve their native state (correct folding or functional conformation), reach their final destination (e.g., the endoplasmic reticulum or the mitochondria), resist denaturing by stressors, and regain the native state after partial denaturation. Thus the Hsps and molecular chaperones occupy the stage's center whenever and wherever there is cellular and tissue injury caused by local or systemic stressors via protein damage. This feature, their participation in protein folding and transport, and their evolutionary conservation within the three phylogenetic domains, strongly suggest a vital role for Hsps and molecular chaperones. Their importance in pathogenesis, and as diagnostic markers and prognostic indicators, is beginning to be appreciated. The role of Hsps and molecular chaperones in cell recovery from injury by a variety of noxae of clinical and surgical relevance is also being assessed. Consequently, the potential of these molecules (and corresponding genes) as targets for treatment or as therapeutic tools is emerging and is being explored. Stroke, myocadial infarction, inflammatory syndromes, infectious and parasitic diseases, autoimmune disorders, cancer, and aging are but some examples of conditions in which Hsps and molecular chaperones are being scrutinized. The era of Hsps and molecular chaperone pathology has dawned. It is likely that genetic and acquired defects of Hsp and molecular chaperone structure and function will be identified, and will play a primary, or auxiliary but determinant, role in disease.

Advances in Research of Small Heat Shock Protein 22 and Clinical Diseases

The Progress of HSP22 Research

Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities

Progress of Study on Heat Shock Proteins

Heat Shock Protein 90 in Neurodegenerative Diseases

Heat-shock proteins and molecular chaperones: implications for pathogenesis, diagnostics, and therapeutics

Heat shock proteins: Cellular and molecular mechanisms in the central nervous system

Small heat-shock proteins: important players in regulating cellular proteostasis

Small heat shock proteins: multifaceted proteins with important implications for life

Mechanistic insights into heat shock protein 27, a potential therapeutic target for cardiovascular diseases

Heat Shock Proteins: Cellular and molecular mechanisms in the CNS

HSP27: Mechanisms of Cellular Protection Against Neuronal Injury.

Heat-shock proteins: new keys to the development of cytoprotective therapies

Progress in the Relationship Between Heat Shock Protein 27 and Ischemia-Reperfusion Injury

Small heat shock protein 22 kDa can modulate the aggregation and liquid-liquid phase separation behavior of tau

The role and therapeutic potential of Hsp90, Hsp70, and smaller heat shock proteins in peripheral and central neuropathies

Thermotolerance and molecular chaperone function of the small heat shock protein HSP20 from hyperthermophilic archaeon, Sulfolobus solfataricus P2

Small Heat Shock Proteins, Big Impact on Protein Aggregation in Neurodegenerative Disease

Different anti-aggregation and pro-degradative functions of the members of the mammalian sHSP family in neurological disorders

Therapeutic applications of heat shock proteins and molecular chaperones